Search Results - "Lodise, T.P"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Severity And Costs Of Acute Bacterial Skin And Skin Structure Infections By Treatment Setting: An Application Of The Eron Classification To A Real-World Database

    Severity And Costs Of Acute Bacterial Skin And Skin Structure Infections By Treatment Setting: An Application Of The Eron Classification To A Real-World Database by Sulham, K, LaPensee, K, Fan, W, Lodise, T.P

    Published in Value in health (01-05-2014)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Efficacy and Hospitalization Length of Stay of Single Dose Oritavancin Compared to 7-10 Days of Vancomycin in Patients with Acute Bacterial Skin and Skin Structure Infections in the Us and Eastern Europe

    Efficacy and Hospitalization Length of Stay of Single Dose Oritavancin Compared to 7-10 Days of Vancomycin in Patients with Acute Bacterial Skin and Skin Structure Infections in the Us and Eastern Europe by LaPensee, K, Fan, W, Fiset, C, Jiang, H, Lodise, T.P

    Published in Value in health (01-11-2014)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Direct Medical Costs and Health Care Resource Utilization Associated with Selected Antibiotic Treatment Pathways in Acute Bacterial Skin and Skin Structure Infections in the United States

    Direct Medical Costs and Health Care Resource Utilization Associated with Selected Antibiotic Treatment Pathways in Acute Bacterial Skin and Skin Structure Infections in the United States by Fan, W, LaPensee, K, Mao, J, Iorga, S, Lodise, T.P

    Published in Value in health (01-11-2013)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    PIN4 - Efficacy and Hospitalization Length of Stay of Single Dose Oritavancin Compared to 7-10 Days of Vancomycin in Patients with Acute Bacterial Skin and Skin Structure Infections in the Us and Eastern Europe

    PIN4 - Efficacy and Hospitalization Length of Stay of Single Dose Oritavancin Compared to 7-10 Days of Vancomycin in Patients with Acute Bacterial Skin and Skin Structure Infections in the Us and Eastern Europe by LaPensee, K., Fan, W., Fiset, C., Jiang, H., Lodise, T.P.

    Published in Value in health (01-11-2014)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    PIN99 - Severity And Costs Of Acute Bacterial Skin And Skin Structure Infections By Treatment Setting: An Application Of The Eron Classification To A Real-World Database

    PIN99 - Severity And Costs Of Acute Bacterial Skin And Skin Structure Infections By Treatment Setting: An Application Of The Eron Classification To A Real-World Database by Sulham, K., LaPensee, K., Fan, W., Lodise, T.P.

    Published in Value in health (01-05-2014)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5 mg/L: A Pilot Study

    Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5 mg/L: A Pilot Study by Martirosov, DM, Bidell, MR, Pai, MP, Scheetz, MH, Rosenkranz, SL, Lodise, TP

    “…Abstract Data suggests that vancomycin is less effective for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) with vancomycin…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    PIN58 - Direct Medical Costs and Health Care Resource Utilization Associated with Selected Antibiotic Treatment Pathways in Acute Bacterial Skin and Skin Structure Infections in the United States

    PIN58 - Direct Medical Costs and Health Care Resource Utilization Associated with Selected Antibiotic Treatment Pathways in Acute Bacterial Skin and Skin Structure Infections in the United States by Fan, W, LaPensee, K., Mao, J., Iorga, S., Lodise, T.P.

    Published in Value in health (01-11-2013)
    Get full text
    Journal Article
    Save to List
    Saved in:
  8. 8
    Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5mg/L: A pilot study

    Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5mg/L: A pilot study by Martirosov, D.M., Bidell, M.R., Pai, M.P., Scheetz, M.H., Rosenkranz, S.L., Lodise, T.P.

    “…Data suggest that vancomycin is less effective for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) with vancomycin Etest® MIC…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: